Malaysian Genomics Resource Centre Bhd (XKLS:0155) E10: RM0.01 (As of Mar. 2026)


XKLS:0155 Malaysian Genomics Resource Centre Bhd XKLS:0155
47 GF Score
Price RM0.27
GF Value RM0.30
Valuation Modestly Undervalued
! 2 Warning Signs
View Full Analysis

What is Malaysian Genomics Resource Centre Bhd E10?

Malaysian Genomics Resource Centre Bhd XKLS:0155 +1.89% 47 E10 is RM0.01 as of Mar. 2026. GuruFocus rates XKLS:0155 with a GF Score™ of 47/100 and a GF Value™ of RM0.30 (Modestly Undervalued). The stock has 2 warning signs investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Malaysian Genomics Resource Centre Bhd's adjusted earnings per share data for the three months ended in Mar. 2026 was RM0.008. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is RM0.01 for the trailing ten years ended in Mar. 2026.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-06-24), Malaysian Genomics Resource Centre Bhd's current stock price is RM0.27. Malaysian Genomics Resource Centre Bhd's E10 for the quarter that ended in Mar. 2026 was RM0.01. Malaysian Genomics Resource Centre Bhd's Shiller PE Ratio of today is 27.00.

During the past 13 years, the highest Shiller PE Ratio of Malaysian Genomics Resource Centre Bhd was 79.00. The lowest was 15.50. And the median was 38.50.


Malaysian Genomics Resource Centre Bhd  (XKLS:0155) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.

Malaysian Genomics Resource Centre Bhd's Shiller P/E Ratio of today is calculated as

Shiller PE Ratio=Share Price/E10
=0.27/0.01
=27.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Shiller P/E Ratio of Malaysian Genomics Resource Centre Bhd was 79.00. The lowest was 15.50. And the median was 38.50.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Malaysian Genomics Resource Centre Bhd E10 Related Terms


Malaysian Genomics Resource Centre Bhd E10 Historical Data

* Premium members only.

The historical data trend for Malaysian Genomics Resource Centre Bhd's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Malaysian Genomics Resource Centre Bhd E10 Chart

Malaysian Genomics Resource Centre Bhd Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 -0.01 0.00 0.01 0.01

Malaysian Genomics Resource Centre Bhd Quarterly Data
Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Sep23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.01 0.01 0.01 0.01 0.01

XKLS:0155 vs TMO, DHR, IDXX: E10 Comparison

For the Diagnostics & Research subindustry, Malaysian Genomics Resource Centre Bhd's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Malaysian Genomics Resource Centre Bhd Shiller PE Ratio vs Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Malaysian Genomics Resource Centre Bhd's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Malaysian Genomics Resource Centre Bhd's Shiller PE Ratio falls into.


XKLS:0155
47GF Score
Malaysian Genomics Resource Centre Bhd XKLS:0155
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Malaysian Genomics Resource Centre Bhd E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Malaysian Genomics Resource Centre Bhd's adjusted earnings per share data for the three months ended in Mar. 2026 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Mar. 2026 (Change)*Current CPI (Mar. 2026)
=0.008/330.2130*330.2130
=0.008

Current CPI (Mar. 2026) = 330.2130.

Malaysian Genomics Resource Centre Bhd Quarterly Data

per share eps CPI Adj_EPS
201512 0.005 236.525 0.007
201603 0.002 238.132 0.003
201606 0.001 241.018 0.001
201609 0.009 241.428 0.012
201612 -0.005 241.432 -0.007
201703 -0.001 243.801 -0.001
201706 0.003 244.955 0.004
201709 -0.008 246.819 -0.011
201712 -0.008 246.524 -0.011
201803 -0.014 249.554 -0.019
201806 -0.014 251.989 -0.018
201809 -0.005 252.439 -0.007
201812 -0.010 251.233 -0.013
201903 -0.009 254.202 -0.012
201906 -0.013 256.143 -0.017
201909 0.000 256.759 0.000
201912 0.234 256.974 0.301
202003 -0.016 258.115 -0.020
202006 -0.053 257.797 -0.068
202009 -0.008 260.280 -0.010
202012 -0.015 260.474 -0.019
202103 0.002 264.877 0.002
202106 -0.019 271.696 -0.023
202109 0.002 274.310 0.002
202112 0.008 278.802 0.009
202203 0.016 287.504 0.018
202206 0.032 296.311 0.036
202209 0.007 296.808 0.008
202212 -0.010 296.797 -0.011
202303 -0.022 301.836 -0.024
202309 -0.011 307.789 -0.012
202403 -0.010 312.332 -0.011
202406 -0.010 314.175 -0.011
202409 -0.007 315.301 -0.007
202412 -0.004 315.605 -0.004
202503 -0.006 319.799 -0.006
202506 -0.003 322.561 -0.003
202509 0.003 324.800 0.003
202512 -0.012 324.054 -0.012
202603 0.008 330.213 0.008

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of RM0.01 mean?
Malaysian Genomics Resource Centre Bhd (XKLS:0155) has a E10 of RM0.01 as of Mar. 2026. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors.
Is Malaysian Genomics Resource Centre Bhd's E10 too high?
Malaysian Genomics Resource Centre Bhd's current E10 is RM0.01. Overall, Malaysian Genomics Resource Centre Bhd has a GF Score™ of 47/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Malaysian Genomics Resource Centre Bhd's E10 compare to TMO and DHR?
Malaysian Genomics Resource Centre Bhd's E10 of RM0.01 can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Diagnostics & Research company?
A good E10 depends on the Medical Diagnostics & Research industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Malaysian Genomics Resource Centre Bhd and its competitors. Malaysian Genomics Resource Centre Bhd's current E10 is RM0.01. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Malaysian Genomics Resource Centre Bhd stock overvalued right now?
Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd (XKLS:0155) is currently considered Modestly Undervalued. The stock's GF Value™ is RM0.30, compared to a current price of RM0.27 — trading 10% below its estimated fair value. The current E10 is RM0.01. Malaysian Genomics Resource Centre Bhd's overall GF Score™ is 47/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Malaysian Genomics Resource Centre Bhd (XKLS:0155), the current E10 is RM0.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Malaysian Genomics Resource Centre Bhd (XKLS:0155) Overvalued in 2026?

Based on GuruFocus' analysis, Malaysian Genomics Resource Centre Bhd stock appears to be undervalued. The current stock price of RM0.27 is trading 10% below its estimated GF Value™ of RM0.30. GuruFocus considers Malaysian Genomics Resource Centre Bhd to be Modestly Undervalued.

Key valuation signals for XKLS:0155:

  • E10: RM0.01
  • GF Value™: RM0.30 vs. price of RM0.27 (10% below fair value)
  • GF Score™: 47/100 with 2 warning signs

No single metric tells the full story. See the XKLS:0155 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Malaysian Genomics Resource Centre Bhd Business Description

Address Jalan Teknologi 3/6, 8F, Taman Sains Selangor 1, Kota Damansara (PJU5), Petaling Jaya, SGR, MYS, 47810
Malaysian Genomics Resource Centre Bhd is a Malaysia-based company. The company's principal activities include enabling personalized and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services, as well as investment holding. It offers genome sequencing and analysis (GSA) services and genetic screening services (GSS). The group offerings include precision genetic screening, project-based analysis, and high-quality cell therapy and cosmeceutical products. The reportable segments of the Group derive their revenue from the provision of personalised and precision medicine through genetics, genomics, immunotherapy, and biopharmaceutical services within the healthcare segment.
47GF Score

Get the complete analysis for XKLS:0155

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

RM0.27
Price
RM0.30
GF Value